Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis

Gastroenterology
Didier LebrecPentocir Group

Abstract

Pentoxifylline, an inhibitor of tumor necrosis factor-alpha, is given to patients with liver diseases, but its effects in patients with advanced cirrhosis are unknown. We performed a randomized, placebo-controlled, double-blind trial of its effects in patients with cirrhosis. A total of 335 patients with cirrhosis (Child-Pugh class C) were assigned to groups given either pentoxifylline (400 mg, orally, 3 times daily; n = 164) or placebo (n = 171) for 6 months. The primary end point was mortality at 2 months. Secondary end points were mortality at 6 months and development of liver-related complications. By 2 months, 28 patients in the pentoxifylline group (16.5%) and 31 in the placebo group (18.2%) had died (P = .84). At 6 months, 50 patients in the pentoxifylline group (30.0%) and 54 in the placebo group (31.5%) had died (P = .75). The proportions of patients without complications (eg, bacterial infection, renal insufficiency, hepatic encephalopathy, or gastrointestinal hemorrhage) were higher in the pentoxifylline group than in the placebo group at 2 months (78.6% vs 63.4%; P = .006) and 6 months (66.8% vs 49.7%; P = .002). The probability of survival without complications was higher in the pentoxifylline group than in the pla...Continue Reading

Associated Clinical Trials

Jan 24, 2013·Sanjiv Harpavat

References

Jun 15, 1990·Annals of Internal Medicine·G L BirdR S Williams
Mar 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C J McClain, D A Cohen
Apr 1, 1993·Immunobiology·P ZabelM Schlaak
Feb 7, 1998·Journal of Hepatology·K J SimpsonS L Kunkel
May 15, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M NavasaJ Rodés
Feb 19, 1999·Lancet·J GoulisA K Burroughs
Jul 28, 1999·Seminars in Liver Disease·J J Maher
Jul 28, 1999·Seminars in Liver Disease·C J McClainD Hill
Aug 2, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M WehlerR Strauss
Dec 20, 2002·Nature·Carl Nathan
Apr 14, 2004·Liver International : Official Journal of the International Association for the Study of the Liver·M OdehA Oliven
May 4, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sylvie NaveauUNKNOWN Foie-Alcool group of the Association Française pour l'Etude du Foie
Mar 22, 2005·Journal of Hepatology·François Durand, Dominique Valla

❮ Previous
Next ❯

Citations

Nov 23, 2010·Current Gastroenterology Reports·Juliane I BeierCraig J McClain
Oct 16, 2013·Nature Reviews. Gastroenterology & Hepatology·Vlad Ratziu
Jul 20, 2011·Antioxidants & Redox Signaling·Amal ChoumarAbdellah Mansouri
Jan 31, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Andrew DavenportMitra K Nadim
Nov 23, 2011·Critical Care : the Official Journal of the Critical Care Forum·Len VerbekeWim Laleman
Jul 14, 2012·World Journal of Gastroenterology : WJG·Marek Hartleb, Krzysztof Gutkowski
Jul 12, 2013·Wiener medizinische Wochenschrift·Verena Wieser, Herbert Tilg
Apr 15, 2014·ISRN Gastroenterology·Tarek Mohammed MostafaMahmoud Samy Abdallah
Mar 26, 2014·Current Opinion in Gastroenterology·Simon Hazeldine, Nick Sheron
Feb 18, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Vlad RatziuKlaudia Traudtner
Jul 24, 2015·Hepatology International·Richard Moreau
Oct 10, 2014·Nursing·Dolores MorrisonLauren H Daniels
Oct 19, 2010·World Journal of Gastroenterology : WJG·Maziyar Amini, Bruce A Runyon
Mar 8, 2014·World Journal of Gastroenterology : WJG·Ludovico AbenavoliGiovanni Addolorato
Mar 15, 2014·World Journal of Gastroenterology : WJG·Tony BrunsAndreas Stallmach
Jun 12, 2013·Current Hepatitis Reports·Laura SmartCraig J McClain
Apr 13, 2013·Wiener klinische Wochenschrift·Markus Peck-RadosavljevicUNKNOWN Austrian Society of Gastroenterology and Hepatology
Sep 16, 2011·Current Opinion in HIV and AIDS·Ulrich Spengler
Feb 24, 2011·Expert Review of Anti-infective Therapy·Melanie R Power CoombsOfer Levy
Feb 4, 2016·Nature Reviews. Gastroenterology & Hepatology·Shiv K Sarin, Ashok Choudhury
Oct 27, 2015·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·François DurandMitra K Nadim
Sep 4, 2013·Gastroenterology·Florence WongUNKNOWN North American Consortium for Study of End-Stage Liver Disease
Jul 3, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ashwani K SingalVijay H Shah
Jul 16, 2013·Néphrologie & thérapeutique·Victor GueutinHassane Izzedine
Feb 4, 2012·Journal of Hepatology·Philippe Mathurin, Michael R Lucey
Nov 29, 2011·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Francesco CorradiMiquel Navasa
Oct 29, 2011·Clinics in Liver Disease·Hui-Hui Tan, Paul Martin
Sep 7, 2011·Gastroenterology Clinics of North America·Ashwani K Singal, Vijay H Shah
Nov 3, 2015·Clinical and Molecular Hepatology·Vijay H Shah
Mar 16, 2013·Alimentary Pharmacology & Therapeutics·R ParkerD D Houlihan
Jun 26, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Emmanuel A TsochatzisAndrew K Burroughs
Nov 22, 2015·Gastroenterología y hepatología·Juan Caballeria
Apr 5, 2016·International Journal of Molecular Sciences·Puiyan LamYibin Feng
Jun 22, 2013·Journal of Hepatology·Tilman Sauerbruch
Oct 2, 2015·Lancet·William BernalAndrew Burroughs
Dec 17, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Juan Caballeria
May 29, 2012·Journal of Hepatology·UNKNOWN European Association for the Study of Liver
Jul 17, 2010·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver
Sep 21, 2010·Journal of Hepatology·Elsa Solà, Pere Ginès
May 20, 2015·Gastroenterology Research and Practice·Jan HeidemannTobias Meister
Oct 15, 2013·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Sylvie Deuffic-BurbanSébastien Dharancy
May 7, 2016·Journal of Hepatology·Giusi MarroneJordi Gracia-Sancho
Jun 3, 2016·Alcoholism, Clinical and Experimental Research·Ashwani K SingalThomas D Schiano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Related Papers

JAMA : the Journal of the American Medical Association
Janet M Torpy
Liver International : Official Journal of the International Association for the Study of the Liver
Vanessa StadlbauerRajiv Jalan
Liver International : Official Journal of the International Association for the Study of the Liver
Deniz Güney DumanNurdan Tözün
© 2021 Meta ULC. All rights reserved